Effective Long-term Knee Pain Management in Chalfont, Pennsylvania
Knee pain management is common in Americans over 45, making it a major health issue for those entering mid-life. Approximately 20% of that population suffers from symptomatic knee osteoarthritis (OA) – a condition characterized by the progressive breakdown of articular cartilage, which results in excruciating pain, loss of mobility, and a significant reduction in quality of life.
Evidence Based Knee Pain Management Treatment
What causes knee pain?
To begin with, osteoarthritis stands out as one of the most common and serious causes of knee pain. It develops more frequently with age and leads to chronic discomfort as the cartilage continues to wear down over time.
In addition, autoimmune conditions can contribute to knee pain by triggering inflammation within the joint. As a result, swelling and stiffness may persist and worsen without proper management.
Furthermore, some individuals are born with structural abnormalities in their bones, which can place extra stress on the knee and lead to ongoing discomfort.
Acute injuries also play a major role. For example, damage to the anterior cruciate ligament (ACL) or the meniscus can cause significant pain and instability in the knee. Altogether, these causes highlight how complex knee pain can be and why a personalized treatment plan is essential.
Conventional Vs Regenerative Knee Pain Management:
Traditionally, healthcare providers focus on reducing pain and improving joint function. Several commonly used approaches include:
- Physical therapy (PT) helps strengthen the muscles around the knee, which improves stability and mobility.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) reduce pain and swelling, especially in the short term.
- Joint stabilizers, such as braces, provide support and make movement easier.
- Corticosteroid injections help reduce inflammation when pain becomes more persistent.
However, modern treatment approaches continue to evolve. Instead of only managing symptoms, many providers now focus on improving the joint environment and supporting the body’s natural healing processes.
For example, platelet-rich plasma (PRP) therapy uses concentrated platelets from the patient’s own blood and injects them into the knee joint. This method can support healing and has shown effectiveness in mild to moderate cases of osteoarthritis.
In more advanced cases, specialists may recommend regenerative treatments that combine stem cells with growth factors. These approaches aim to repair damaged tissue, reduce inflammation, and improve long-term joint function.
Is Total Knee Replacement (TKR) surgery the last resort to regain mobility?
Patients suffering from severe knee pain from chronic diseases like osteoarthritis are often left with no choice other than Total Knee Replacement (TKR) to regain mobility. But the complex surgical procedure and the prolonged recovery with intense pain is a major point of hesitation for many patients. But the good news is with regenerative medicine a surgery can be avoided in some instances. There is a minimally invasive regenerative strategy for certain cases to effectively manage pain, decrease recovery time and improve quality of life.
BMAC Therapy
Additionally, our team of experts will determine the most suitable treatment plan for you based on a thorough prognosis, this may include BMAC therapy. Our personalized approach ensures you receive care that is tailored to your specific needs and goals
What is in BMAC?
BMAC comprising mesenchymal stem cells along with various anti-inflammatory growth factors that these cells secrete; has been shown to be effective in managing pain, reducing inflammation and promoting cartilage regeneration in severe cases of osteoarthritis6. It can treat most advanced stages of knee pain caused by osteoarthritis, structural and congenital issues, inflammatory and autoimmune conditions, overuse and repetitive strain, post-traumatic arthritis etc.
The primary constituent of this procedure is stem cells. Stem cells are the specialized cells within our body, that, when required, can generate multiple different types of cells. These cells are the reasons why our body can heal itself. The bone marrow (jelly-like substance inside long bones) is one of the major repositories of these stem cells – especially a specific type of stem cell called mesenchymal stem cells. For more than 30 years bone marrow aspirates comprising of these mesenchymal stem cells with amazing healing properties have been used in regenerative medicines, especially for orthopedic applications5
Why this is effective?
BMAC is unique as it combines the patients’ own regenerative cells and anti-inflammatory growth factors to be delivered in a precise, targeted and minimally invasive manner.
What is the duration of this procedure?
In most cases a single intra-articular injection of BMAC is used for treating knee osteoarthritis. BMAC has demonstrated better clinical function (pain relief and function for up to 2 years)2. The BMAC procedure is generally a “one-step” process, meaning the ideal candidate can expect bone marrow harvesting, processing and concentration, and injection are all performed on a single day visit7.
What can recovery include?
Unlike TKR surgery, Bone Marrow Aspirate Concentrates therapy takes significantly less time to recover. From initial downtime of 3-7 days with mild soreness to 3-6 months for complete recovery and regaining the normal mobility, BMAC in most of the cases has proven to be a really fast and effective restoration procedure. Research shows that BMAC injections are generally safe and much more effective in treating pain and improve mobility in patients with symptomatic knee OA than PRP injections2.
However, an expert can determine if an individual is the right candidate to undergo this procedure as it needs some specific conditions to be checked.
References
- Wallace IJ, Worthington S, Felson DT, Jurmain RD, Wren KT, Maijanen H, Woods RJ, Lieberman DE. Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):9332-9336. doi: 10.1073/pnas.1703856114. Epub 2017 Aug 14. PMID: 28808025; PMCID: PMC5584421.
- El-Kadiry AE, Lumbao C, Salame N, Rafei M, Shammaa R. Bone marrow aspirate concentrate versus platelet-rich plasma for treating knee osteoarthritis: a one-year non-randomized retrospective comparative study. BMC Musculoskelet Disord. 2022 Jan 3;23(1):23. doi: 10.1186/s12891-021-04910-5. PMID: 34980045; PMCID: PMC8725314.
- Bensa A, Previtali D, Sangiorgio A, Boffa A, Salerno M, Filardo G. PRP Injections for the Treatment of Knee Osteoarthritis: The Improvement Is Clinically Significant and Influenced by Platelet Concentration: A Meta-analysis of Randomized Controlled Trials. Am J Sports Med. 2025 Mar;53(3):745-754. doi: 10.1177/03635465241246524. Epub 2025 Jan 3. PMID: 39751394; PMCID: PMC11874499.
- Bennell KL, Paterson KL, Metcalf BR, Duong V, Eyles J, Kasza J, Wang Y, Cicuttini F, Buchbinder R, Forbes A, Harris A, Yu SP, Connell D, Linklater J, Wang BH, Oo WM, Hunter DJ. Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial. JAMA. 2021 Nov 23;326(20):2021-2030. doi: 10.1001/jama.2021.19415. PMID: 34812863; PMCID: PMC8611484.
- Berebichez-Fridman R, Gómez-García R, Granados-Montiel J, Berebichez-Fastlicht E, Olivos-Meza A, Granados J, Velasquillo C, Ibarra C. The Holy Grail of Orthopedic Surgery: Mesenchymal Stem Cells-Their Current Uses and Potential Applications. Stem Cells Int. 2017;2017:2638305. doi: 10.1155/2017/2638305. Epub 2017 Jun 18. PMID: 28698718; PMCID: PMC5494105.
- Holton J, Imam M, Ward J, Snow M. The Basic Science of Bone Marrow Aspirate Concentrate in Chondral Injuries. Orthop Rev (Pavia). 2016 Sep 30;8(3):6659. doi: 10.4081/or.2016.6659. PMID: 27761221; PMCID: PMC5066111.
- Chahla J, Mannava S, Cinque ME, Geeslin AG, Codina D, LaPrade RF. Bone Marrow Aspirate Concentrate Harvesting and Processing Technique. Arthrosc Tech. 2017 Apr 10;6(2):e441-e445. doi: 10.1016/j.eats.2016.10.024. PMID: 28580265; PMCID: PMC5443590.
